-
Traders Get Adventurous With Leveraged Biotech ETFs
Wednesday, October 28, 2015 - 3:12pm | 671After a third-quarter swoon that saw the iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB) and the SPDR S&P Biotech (ETF) (NYSE: XBI), two of the largest biotech exchange-traded funds by assets, tumble 18.1 percent and 24.4 percent, respectively, traders have displayed caution regarding...